These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 314185

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK, Sundstrom C, Yu AL, Levine A.
    Nat Immun Cell Growth Regul; ; 3(4):165-80. PubMed ID: 6597341
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Natural killer activity in patients with acute myelocytic leukemia.
    Stupp Y, Rosenkovitch E, Izak G.
    Isr J Med Sci; 1978 Dec; 14(12):1212-5. PubMed ID: 311767
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
    Dermime S, Mavroudis D, Jiang YZ, Hensel N, Molldrem J, Barrett AJ.
    Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
    [Abstract] [Full Text] [Related]

  • 10. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. I. Role of HLA-DR antigens as stimulatory molecules.
    Matera L, Francis MK, Herlyn M, Trucco M, Santoli D.
    Nat Immun Cell Growth Regul; 1985 May; 4(2):90-102. PubMed ID: 3160934
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bone marrow modulaton of spontaneous killer cellular cytotoxicity (SKCC) induction.
    Targan SR, Gale RP, Jondal M.
    J Clin Lab Immunol; 1980 Jul; 4(1):1-6. PubMed ID: 6970266
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A, Ferm MT, Ng J, Reynolds CW, Ortaldo JR.
    J Immunol; 1988 Jun 15; 140(12):4397-402. PubMed ID: 3131433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.